to evaluate breadth and duration of protection conferred by OVX836 against seasonal and highly pathogenic influenza strains, informing its potential as a vaccine for long-term prevention of seasonal and pandemic influenza

Grant number: INV-051738

Grant search

Key facts

  • Disease

    Unspecified
  • start year

    2023
  • Known Financial Commitments (USD)

    $1,124,202
  • Funder

    Gates Foundation
  • Principal Investigator

    N/A

  • Research Location

    France
  • Lead Research Institution

    Osivax
  • Research Priority Alignment

    N/A
  • Research Category

    Vaccines research, development and implementation

  • Research Subcategory

    Characterisation of vaccine-induced immunity

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

N/A